Model
Edge
Albireo Pharma, Inc.
0001322505
Filing Type
SC TO-T
Filing Date
1/22/2023
Updated
1/23/23, 1:11 AM
Filing
SC TO-T
Earnings Release
Exhibits
SC TO-T
Tender Offer Statement by Third Party
EX-99.(A)(1)(A)
OFFER TO PURCHASE
EX-99.(A)(1)(B)
LETTER OF TRANSMITTAL
EX-99.(A)(1)(C)
NOTICE OF GUARANTEED DELIVERY
EX-99.(A)(1)(D)
LETTER TO BROKERS,DEALERS,COMMERCIAL BANKS, TRUST COMPANIES AND OTHER NOMINEES
EX-99.(A)(1)(E)
LETTER TO CLIENTS FOR USE BY BROKERS, DEALERS, ETC
EX-99.(A)(1)(F)
FORM OF SUMMARY ADVERTISEMENT
EX-99.(B)(1)
REVOLVING FACILITY AGREEMENT
EX-99.(D)(2)(A)
MUTUAL CONFIDENTIALITY AGREEMENT, BY AND BETWEEN ALBIREO AND IPSEN BIOSCIENCE IN
EX-99.(D)(2)(B)
MUTUAL CONFIDENTIALITY AGREEMENT, BY AND BETWEEN ALBIREO AND GUARANTOR
EX-99.(D)(3)
EX-99.(D)(3)
EX-FILING FEES
EX-FILING FEES
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic
GRAPHIC
Graphic